Clinical Trial Update: SPIRIVA in Ususal Care [Phase 4]

View source ↗

Summary

A Phase 4 trial update shows the SPIRIVA study in usual care for COPD has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Spiriva (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 4 | Status: COMPLETED